A. B. FERHANOĞLU Et Al. , "Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Real-Life Experience," 4th Aegean Hematology Oncology Symposium , vol.1, Rodos, Greece, pp.1, 2017
FERHANOĞLU, A. B. Et Al. 2017. Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Real-Life Experience. 4th Aegean Hematology Oncology Symposium , (Rodos, Greece), 1.
FERHANOĞLU, A. B., BEKÖZ, H. S., KARADURMUŞ, N., PAYDAŞ, S., TÜRKER, F. A., TOPTAŞ, T., ... TUĞLULAR, A. T.(2017). Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Real-Life Experience . 4th Aegean Hematology Oncology Symposium (pp.1). Rodos, Greece
FERHANOĞLU, AHMET Et Al. "Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Real-Life Experience," 4th Aegean Hematology Oncology Symposium, Rodos, Greece, 2017
FERHANOĞLU, AHMET B. Et Al. "Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Real-Life Experience." 4th Aegean Hematology Oncology Symposium , Rodos, Greece, pp.1, 2017
FERHANOĞLU, A. B. Et Al. (2017) . "Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Real-Life Experience." 4th Aegean Hematology Oncology Symposium , Rodos, Greece, p.1.
@conferencepaper{conferencepaper, author={AHMET BURHAN FERHANOĞLU Et Al. }, title={Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Real-Life Experience}, congress name={4th Aegean Hematology Oncology Symposium}, city={Rodos}, country={Greece}, year={2017}, pages={1} }